In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2739-2744

  Lowdin E ^a   Odenholt, I ^a   Cars, O ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0344936720     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2739     Document Type: Article

References (35)

1. Ackerman, B. H., A. M. Vanner, and E. B. Eudy. 1992. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob. Agents Chemother. 36:1766-1769.
2. Blaser, J. 1985. Two compartment kinetic model with multiple artificial capillary units. J. Antimicrob. Chemother. 15(Suppl. A):131-137.
3. Bundtzen, R. W., A. U. Gerber, D. L. Cohn, and W. A. Craig. 1981. Postantibiotic suppression of bacterial growth. Rev. Infect. Dis. 3:28-37.
4. Cooper, M. A., Y. F. Jin, J. M. Andrews, and R. Wise. 1990. In-vitro comparison of the postantibiotic effect of vancomycin and teicoplanin. J. Antimicrob. Chemother. 26:203-207.
5. Craig, W. A., and S. Gudmundsson. 1986. The postantibiotic effect, p. 515-536. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
6. Duffull, S. B., E. J. Begg, T. Chambers, and M. L. Barclay. 1994. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model. Antimicrob. Agents Chemother. 38:2480-2482.
7. Ehrenkranz, N. J. 1959. The clinical evaluation of vancomycin in treatment of multiantibiotic refractory staphylococcal infections, p. 587-594. In Antibiotics annual. 1958-1959. Medical Encyclopedia, Inc., New York, N.Y.
8. Ericsson, H. M., and J. C. Sherris. 1971. Antibiotic sensitivity testing-report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B Suppl. 217:3-90.
9. Flandrois, J. P., G. Fardel, and G. Carret. 1988. Early stages of in vitro killing curve of LY 146032 and vancomycin for Staphylococcus aureus. Antimicrob. Agents Chemother. 32:454-457.
10. Geraci, J. E., F. R. Heilman, D. R. Nichols, W. E. Wellman, and G. T. Rooss. 1956. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc. Mayo Clin. 31:564-582.
11. Grasso, S., G. Meinardi, I. de Carneri, and V. Tamassia. 1978. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob. Agents Chemother. 13:570-576.
12. Greenberg, R. N., and C. Benes. 1990. Time-kill studies with oxacillin, vancomycin and teicoplanin versus Staphylococcus aureus. J. Infect. Dis. 161: 1036-1037.
13. Greenwood, D., and H. Tupper. 1981. New in vitro device for examining the response of bacteria to changing drug concentrations. Curr. Chemother. Immunother. 1981:100-102.
14. Greenwood, D., K. Bidgood, and M. Turner. 1987. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. J. Antimicrob. Chemother. 20:155-164.
15. Griffith, R. S. 1957. Vancomycin: continued clinical studies, p. 118-122. In Antibiotics annual, 1956-1957. Medical Encyclopedia, Inc., New York, N.Y.
16. 2+ and albumin on these drugs. Antimicrob. Agents Chemother. 35:1710-1716.
17. Healy, D. P., R. E. Polk, M. L. Garson, U. T. Rock, and T. J. Comstock. 1987. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob. Agents Chemother. 31:393-397.
18. Krogstad, D. J., R. C. Moellering, and D. J. Greenblatt. 1980. Single-dose kinetics of intravenous vancomycin. J. Clin. Pharm. 20:197-201.
19. Lagast, H., P. Didion, and J. Klastersky. 1986. Comparison of pharmacokinetics and bactericidal activity of tecoplanin and vancomycin. J. Antimicrob. Chemother. 18:513-520.
20. Lopez-Lopez, G., A. Pauscal, and E. J. Perea. 1991. Effect of plastic catheter material on bacterial adherence and viability. J. Med. Microbiol. 34:349-353.
21. Louria, D. B., T. Kaminski, and J. Buchman. 1961. Vancomycin in severe staphylococcal infections. Arch. Intern. Med. 107:225-240.
22. Lowdin, E., I. Odenholt-Tornqvist, S. Bengtsson, and O. Cars. 1993. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob. Agents Chemother. 37:2200-2205.
23. Löwdin, E., I. Odenholt, and O. Cars. 1996. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model. Antimicrob. Agents Chemother. 40:2478-2482.
24. McDonald, P. J., W. A. Craig, and C. M. Kunin. 1977. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135:217-223.
25. Navashin, S. M., I. P. Fomina, A. A. Firsov, C. M. Chernykh, and S. M. Kuznetsova. 1989. A dynamic model for in-vitro evaluation of antimicrobial action by simulation of the pharmacokinetic profiles of antibiotics. J. Antimicrob. Chemother. 23:389-399.
26. Odenholt, I., S. E. Holm, and O. Cars. 1989. Effects of benzylpenicillin on group A β-hemolytic streptococci during the postantibiotic phase in vitro. J. Antimicrob. Chemother. 24:147-156.
27. Odenholt-Tornqvist, I., E. Lowdin, and O. Cars. 1991. Pharmacodynamic effects of subinhihitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
28. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1992. The postantibiotic sub-MIC effect of vancomycin, roxitromycin, sparfloxacin, and amikacin. Antimicrob. Agents. Chemother. 36:1852-1858.
29. Pascual, A., A. Fleer, N. A. Westerdaal, and J. Verhof. 1986. Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur. J. Clin. Microbiol. 5:518-522.
30. Peetermans, W. E., J. J. Hoogeterp, A.-M. Hazekamp von Dokkum, P. van den Broek, and H. Mattie. 1990. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. Antimicrob. Agents Chemother. 34:1869-1874.
31. Raddatz, J. K., A. J. Larsson, K. J. Walker, and J. C. Rotschafer. 1995. Concentration-independent effect of monoexponential and biexponential decay of vancomycin (VM) in the killing of S. aureus (SA) under aerobic and anaerobic conditions, abstr. A101, p. 19. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Ramirez de Arellano, E., A. Pauscal, L. Martinez-Martinez, and E. J. Perea. 1994. Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. J. Med. Microbiol. 40:43-47.
33. Reeves, D. S. 1985. Advantages and disadvantages of an in-vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin. J. Antimicrob. Chemother. 15(Suppl. A):159-167.
34. Small, P. M., and H. F. Chambers. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
35. Wilson, D. A., and G. A. Rolinson. 1979. The recovery period following exposure of bacteria to penicillins. Chemotherapy (Basel) 25:14-22.